...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Quality of life research: An international journal of quality of life aspects of treatment, care and rehabilitation >PROMIS depression measures perform similarly to legacy measures relative to a structured diagnostic interview for depression in cancer patients
【24h】

PROMIS depression measures perform similarly to legacy measures relative to a structured diagnostic interview for depression in cancer patients

机译：PROMIS depression measures perform similarly to legacy measures relative to a structured diagnostic interview for depression in cancer patients

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相关主题

摘要

Purpose To assess the convergent validity of the Patient-Reported Outcomes Measurement Information System (PROMIS) depression measures relative to legacy measures and criterion validity against a structured diagnostic interview for depression in an oncology sample. Methods 132 oncology/haematology outpatients completed the PROMIS Depression Computer Adaptive Test (PROMIS-D-CAT) and PROMIS Depression Short Form (PROMIS-D-SF) along with seven legacy measures: Beck Depression Inventory (BDI); Centre for Epidemiological Studies Depression (CES-D); Depression, Anxiety and Stress Scale; Hospital Anxiety and Depression Scale; Patient Health Questionnaire; Distress Thermometer and PSYCH-6. Correlations, area under the curve (AUC) and diagnostic accuracy statistics were calculated with Structured Clinical Interview as the gold standard. Results Both PROMIS measures correlated with all legacy measures at p ? ?0.800) were comparable. At the cut-off points for mild depression of 53, the PROMIS measures had sensitivity (0.83 for PROMIS-D-CAT and 0.80 for PROMIS-D-SF) similar to or better than 6/7 legacy measures with high negative predictive value (>?90). At cut-off points of 60 for moderate depression, PROMIS measures had specificity?>?90, similar to or better than all legacy measures and positive predictive value?≥?0.50 (similar to 5/7 legacy measures). Conclusions The convergent and criterion validity of the PROMIS depression measures in cancer populations was confirmed, although the optimal cut-off points are not established. PROMIS measures were briefer than BDI-II and CES-D but do not offer any advance in terms of diagnostic accuracy, reduced response burden or cost over other legacy measures of depression in oncology patients.

著录项

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号